Login / Signup

Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials.

Jennifer Susan LeesPeter HanlonElaine W ButterlySarah H WildFrances S MairRod S TaylorBruce GuthrieKatie GilliesSofia DiasNicky J WeltonDavid A McAllister
Published in: BMJ medicine (2022)
Increased comorbidity count, irrespective of age and sex, is associated with a modest increased odds of participant attrition. The benefit of increased generalisability of including participants with multimorbidity seems likely to outweigh the disadvantages of increased attrition.
Keyphrases
  • clinical trial
  • study protocol
  • phase ii
  • electronic health record
  • machine learning
  • big data
  • open label